Ceftobiprole clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses ceftobiprole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ceftobiprole
- 7
Studies by the year they started
7 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses ceftobiprole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal DiseaseCompletedPhase 1Basilea PharmaceuticaNCT01030731Written as Ceftobiprole
- A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese PatientsCompletedPhase 1Basilea PharmaceuticaNCT01026558Written as Ceftobiprole
- Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy VolunteersCompletedPhase 1Basilea PharmaceuticaNCT01026740Written as Ceftobiprole
- Pharmacokinetic Study of the Penetration of Ceftobiprole in the BoneCompletedPhase 1Basilea PharmaceuticaNCT00771524Written as Ceftobiprole
- Effect of Ceftobiprole on Human Intestinal MicrofloraCompletedPhase 1Basilea PharmaceuticaNCT00965042Written as Ceftobiprole
- Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated PneumoniaTerminatedPhase 1Basilea PharmaceuticaNCT00771719Written as Ceftobiprole
- A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of AgeCompletedPhase 1Basilea PharmaceuticaNCT01026636Written as Ceftobiprole
Codes
What other systems call ceftobiprole · ClinicalTrials.gg INT004409
- MeSH (NLM) C443755ceftobiproleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5T97333YZKCEFTOBIPROLEConfirmed FDA, NLM, Wikidata
- Wikidata Q5057301ceftobiproleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65306CeftobiproleOne source FDA
- DrugBank DB04918One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C443755 | ceftobiprole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5T97333YZK | CEFTOBIPROLE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5057301 | ceftobiprole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65306 | Ceftobiprole | One source FDA |
| DrugBank | DB04918 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.